Drug Trial Radar · NCT00392106
High Intensity Focused Ultrasound (HIFU) Ablation System Study
Last checked: Nov 20, 2026Latest source record: Jun 17, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Suspended
Enrollment
240
Planned (sponsor's estimate)
Start
Apr 2006
Primary completion
Dec 2010
Study completion Jun 2011
Sponsor
- Lead sponsor
- ProRhythm, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 25, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if the HIFU Pulmonary Vein Ablation System is effective in the treatment of paroxysmal Atrial Fibrillation compared to the control of best medical therapy with FDA approved antiarrhythmic drugs.
Conditions
- Atrial Fibrillation
Interventions
propafenoneDrug
Anti-arrhythmic drug prescribed for treatment of atrial fibrillation
flecainideDrug
Anti-arrhythmic drug prescribed for the treatment of Atrial fibrillation
dofetilideDrug
Anti-arrhythmic drug prescribed for treatment of atrial fibrillation
sotololDrug
Anti-arrhythmic Drug prescribed for treatment of Atrial Fibrillation
Pulmonary vein ablationDevice
Electrical isolation of pulmonary vein with high-intensity focused ultrasound
AmiodaroneDrug
Anti-arrhythmic Drug prescribed for the treatment of Atrial Fibrillation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Acute treatment with elimination of AF episodesTime frame: 12 months
- Death, stroke, and hospitalization for recurrence of AFTime frame: within 12 months of treatment
Locations
21 sites in 2 countries. Site status is shown where the registry gives one.
Fullerton Vascular Medical Group
Fullerton, California
University of California, Los Angeles
Los Angeles, California
Piedmont Hospital
Atlanta, Georgia
Lexington Central Baptist Hospital
Lexington, Kentucky
Johns Hopkins Hopsital
Baltimore, Maryland
Lahey Clinic
Burlington, Massachusetts
Beaumont Hospital
Royal Oak, Michigan
New York University Hospital
New York, New York
Stony Brook University Hospital
Stony Brook, New York
Wake Forest University Health Systems
Winston-Salem, North Carolina
Hillcrest Hospital
Cleveland, Ohio
Cleveland Clinic Foundation
Cleveland, Ohio
The Ohio State University Heart Center
Columbus, Ohio
Oklahoma University Health Sciences Center
Oklahoma City, Oklahoma
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Medical University of South Carolina
Charleston, South Carolina
Texas Cardiac Arrhythmia Research
Austin, Texas
University of Texas, Southwestern
Dallas, Texas
University of Virginia
Charlottesville, Virginia
Sentara Norfolk General Hospital
Norfolk, Virginia
Homolka Hospital
Prague, Czechia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.